CSMD2 gene
Evidence from:
primary |
all sources
Related entities (6)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| associated SNPs | associated_with | CSMD2 | — | 1 |
| CSMD2 | associated_with | addiction phenotypes | — | 1 |
| CSMD2 | expressed_in | brain | — | 1 |
| CSMD2 | expressed_in | fetal brain | — | 1 |
| CSMD2 | expressed_in | spinal cord | — | 1 |
| CSMD2 | associated_with | substance use | — | 1 |
Mentioned in (3)
Papers in which this entity is mentioned.
- Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group. (2018)
- Dosage transmission disequilibrium test (dTDT) for linkage and association detection. (2013)
- Genome-wide association studies in ADHD. (2009)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| csmd2 | gene | 3 | 5 |